Tempest Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
Tempest Therapeutics, Inc. (TPST) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number of 799.90 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber · last filed 2026-08-13
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 799.90K shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 897.64K shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 450.10K shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 450.10K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number |
|---|---|
| 2026-06-30 | 799.90K shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 897.64K shares 10-Q · filed 2026-05-14 |
| 2025-12-31 | 450.10K shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 450.10K shares 10-Q · filed 2025-11-05 |
| 2025-06-30 | 450.10K shares 10-Q · filed 2025-08-11 |
| 2025-03-31 | 450.10K shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 4.16M shares 10-K · filed 2025-03-27 |
| 2024-09-30 | 4.15M shares 10-Q · filed 2024-11-12 |
| 2024-06-30 | 4.01M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 3.94M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 3.55M shares 10-K · filed 2024-03-19 |
| 2023-09-30 | 2.18M shares 10-Q · filed 2023-11-08 |
| 2023-06-30 | 2.19M shares 10-Q · filed 2023-08-10 |
| 2023-03-31 | 2.15M shares 10-Q · filed 2023-05-10 |
| 2022-12-31 | 1.55M shares 10-K · filed 2023-03-22 |
| 2022-09-30 | 1.64M shares 10-Q · filed 2022-11-08 |
| 2022-06-30 | 1.65M shares 10-Q · filed 2022-08-15 |
| 2022-03-31 | 1.08M shares 10-Q · filed 2022-05-13 |
| 2021-12-31 | 790.48K shares 10-K · filed 2022-03-29 |
| 2021-09-30 | 735.93K shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 799.82K shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 2.04M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 1.82M shares 10-K · filed 2021-03-29 |
| 2020-09-30 | 1.36M shares 10-Q · filed 2020-11-09 |
| 2020-06-30 | 1.40M shares 10-Q · filed 2020-08-10 |
| 2020-03-31 | 1.23M shares 10-Q · filed 2020-05-08 |
| 2019-12-31 | 984.26K shares 10-K · filed 2020-03-11 |
| 2019-09-30 | 992.97K shares 10-Q · filed 2019-11-13 |
| 2019-06-30 | 893.21K shares 10-Q · filed 2019-08-12 |
| 2019-03-31 | 891.96K shares 10-Q · filed 2019-05-15 |
| 2018-12-31 | 925.34K shares 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |